Cargando…

Gastrointestinal Colonization of Carbapenem-Resistant Acinetobacter baumannii: What Is the Implication for Infection Control?

The epidemiology of patients with gastrointestinal colonization of carbapenem-resistant Acinetobacter baumannii (CRAB) has not been systematically analyzed. We aimed to analyze the incidence, risk factors, and clinical outcomes of patients with newly identified gastrointestinal colonization of CRAB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Shuk-Ching, Chen, Jonathan Hon-Kwan, Chau, Pui-Hing, So, Simon Yung-Chun, AuYeung, Christine Ho-Yan, Yuen, Lithia Lai-Ha, Chan, Veronica Wing-Man, Lam, Germaine Kit-Ming, Chiu, Kelvin Hei-Yeung, Ho, Pak-Leung, Lo, Janice Yee-Chi, Yuen, Kwok-Yung, Cheng, Vincent Chi-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598245/ https://www.ncbi.nlm.nih.gov/pubmed/36289955 http://dx.doi.org/10.3390/antibiotics11101297

Ejemplares similares

Control of Healthcare-Associated Carbapenem-Resistant Acinetobacter baumannii by Enhancement of Infection Control Measures
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

Epidemiology of multidrug-resistant organisms before and during COVID-19 in Hong Kong
por: Wong, Shuk-Ching, et al.
Publicado: (2023)

Infection of healthcare workers despite a high vaccination rate during the fifth wave of COVID-19 due to Omicron variant in Hong Kong
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

Absence of nosocomial influenza and respiratory syncytial virus infection in the coronavirus disease 2019 (COVID-19) era: Implication of universal masking in hospitals
por: Wong, Shuk-Ching, et al.
Publicado: (2020)

Air dispersal of multidrug-resistant Acinetobacter baumannii: implications for nosocomial transmission during the COVID-19 pandemic
por: Wong, S.-C., et al.
Publicado: (2021)

Preparation for the next pandemic: challenges in strengthening surveillance
por: Chiu, Kelvin Hei-Yeung, et al.
Publicado: (2023)

Evolution and Control of COVID-19 Epidemic in Hong Kong
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic
por: Cheng, Vincent Chi-Chung, et al.
Publicado: (2022)

Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital
por: Chang, Yaowen, et al.
Publicado: (2015)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia
por: Lee, Yi-Tzu, et al.
Publicado: (2016)

Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19
por: Wong, Shuk-Ching, et al.
Publicado: (2021)

Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France
por: Jeannot, Katy, et al.
Publicado: (2014)

Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii
por: Pagano, Mariana, et al.
Publicado: (2016)

Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany
por: Klotz, Peter, et al.
Publicado: (2019)

Heterocyclic Diaryliodonium-Based Inhibitors of Carbapenem-Resistant Acinetobacter baumannii
por: Kumari, Pooja, et al.
Publicado: (2023)

In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Minimal Intervention for Controlling Nosocomial Transmission of Methicillin-Resistant Staphylococcus aureus in Resource Limited Setting with High Endemicity
por: Cheng, Vincent Chi-Chung, et al.
Publicado: (2014)

O047: The effect of active surveillance culture of carbapenem resistant Acinetobacter baumannii on the occurrence of carbapenem resistant Acinetobacter baumannii bacteremia in a single intensive care unit
por: Kim, G, et al.
Publicado: (2013)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Prevalence of different carbapenemase genes among carbapenem-resistant Acinetobacter baumannii blood isolates in Taiwan
por: Wang, Teng-Ho, et al.
Publicado: (2018)

Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii
por: Vashist, Jitendra, et al.
Publicado: (2011)

Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid
por: Nigro, Steven J., et al.
Publicado: (2015)

Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran
por: Farshadzadeh, Zahra, et al.
Publicado: (2015)

Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland
por: Ramette, A., et al.
Publicado: (2018)

Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection
por: Hawkey, Jane, et al.
Publicado: (2018)

Is Aerosalization a Problem With Carbapenem-Resistant Acinetobacter baumannii in Thailand Hospital?
por: Apisarnthanarak, Anucha, et al.
Publicado: (2016)

Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
por: Park, Sang-Won
Publicado: (2019)

Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii
por: Hamidian, Mohammad, et al.
Publicado: (2019)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii
por: Yang, Tsung-Ying, et al.
Publicado: (2021)

Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolates from Clinical Specimens
por: Abdullah, Khansaa, et al.
Publicado: (2021)

Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
por: Gontijo, Aline Vidal Lacerda, et al.
Publicado: (2021)

Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
por: Bartal, Carmi, et al.
Publicado: (2022)

Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit
por: Jiang, Yuan, et al.
Publicado: (2022)

Characterisation of pellicle-forming ability in clinical carbapenem-resistant Acinetobacter baumannii
por: Ng, Heng Kang, et al.
Publicado: (2023)

Endemicity and diversification of carbapenem-resistant Acinetobacter baumannii in an intensive care unit
por: Doughty, Emma L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a0igfqd89kifl5le6jkgjema93